For decades, concussion care has focused on identifying the injury. Today's research is increasingly exploring what comes after diagnosis. Oragenics' lead investigational candidate, ONP-002, is being evaluated in a Phase IIa clinical trial as part of that evolving landscape. Explore trial progress updates: $OGEN
published
For decades, concussion care has focused on identifying the injury. Today's research is increasingly exploring what comes after diagnosis. Oragenics' lead investigational candidate, ONP-002, is being evaluated in a Phase IIa clinical trial as part of that evol
$OGEN
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.